• Phase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors

    Not yet recruiting

    2 1 1
    France Ireland Italy Romania Spain
  • Evaluation of V-Cu64 versus V-Ga68 PET-CT imaging in adults with diagnosed or suspected neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Poland
  • Phase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Czechia France Poland Romania Spain
  • Safety and effectiveness of ponatinib and asciminib in chronic myeloid leukemia patients resistant to these drugs

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Spain
  • Study of FLUDEOXYGLUCOSE (18F) PET Imaging of Brain Metabolism in Patients with Persistent Post‑COVID Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1
    Investigated diseases:
    France Italy Poland Spain
  • Atorvastatin, Placebo, and No Treatment in Adults with Familial Hypercholesterolaemia and Statin-Associated Muscle Symptoms

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Prifetrastat (PF-07248144) Plus Fulvestrant in Adults With Advanced HR+/HER2- Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitor Treatment

    Not yet recruiting

    2 1 1 1
    France
  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Germany
  • Progesterone as an Ovulation Trigger in Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal

powered by